EM2308D "Guarding Your Gut: Understanding Colon Cancer Screening" (IM GR-081823)
Purpose and Overview
Colorectal cancer is a common cancer diagnosis and the second highest cause of cancer death in both men and women in the US. Overall, the risk of colon cancer has been decreasing since the late 1990s, in part because of the success of colonoscopy screening programs. There are now multiple modalities of colon cancer screening, which include but are not limited to stool hemoglobin testing, stool DNA testing, CT colonoscopy, and endoscopic evaluation (including optical colonoscopy). While colon cancer screening is at an all-time high, compliance is still lower than the goal of 80% by 2030. The lecturer hopes to educate the audience in the data and limitations behind each colorectal cancer screening modality and offer suggestions on how to maximize educational conversations with patients on the subject of colorectal cancer risk and screening.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Recognize that colorectal cancer is presenting at younger ages which is why most recent guidelines recommend starting screening at age 45 for average risk patients.
- Recognize and differentiate between the different colorectal cancer screening modalities and gain knowledge of how to convince our patients.
- Recognize that positive CRC screening testing other than colonoscopy will necessitate diagnostic colonoscopy.
Amy Lo, M.D.
Assistant Professor of Internal Medicine
Division of Digestive & Liver Diseases
- 1.00 AMA